This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Getty Images milla1cf Wed, 06/05/2024 - 20:33 June 5, 2024 — Edwards Lifesciences announced it has entered into a definitive agreement to sell its CriticalCare product group to BD (Becton, Dickinson and Company), in an all-cash transaction valued at $4.2
These two acquisitions could impact Edwards’ structural heart and heart failure portfolios in unique and meaningful ways… JenaValve’s Trilogy TAVR system doesn’t yet have FDA approval, but is CE Marked for both aortic regurgitation and aortic stenosis, which is notable given that all other TAVR systems only address aortic stenosis.
An international group of experts in HGPS, pediatric and adult cardiology, cardiac surgery, and pediatric criticalcare convened to identify strategies for successful treatment. Modified transcatheter aortic valve replacement (TAVR) and left ventricular Apico-Aortic Conduit (AAC) placement were deemed high risk but viable options.
ET – E/M, CriticalCare Q&A 10:45 a.m. Summarize the necessary documentation and regulations relevant to criticalcare and cardiothoracic surgery E/M services for 2023. ET – Adult Cardiac Q&A 5:15 p.m. ET – 6:00 p.m. ET – Congenital Cardiac Q&A 6:00 p.m. ET – 6:45 p.m. ET – 10:45 a.m. ET – 11:30 a.m.
Ram Kumar The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2021 Update on Outcomes and Research The Annals of Thoracic Surgery December 2021 Jennifer Nelson Capturing Adult Congenital Heart Disease: Framework for Development of an Adult Congenital Heart Disease Mortality Risk Model The Annals of Thoracic Surgery November 2021 Laura (..)
Ram Kumar The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2021 Update on Outcomes and Research The Annals of Thoracic Surgery December 2021 Jennifer Nelson Capturing Adult Congenital Heart Disease: Framework for Development of an Adult Congenital Heart Disease Mortality Risk Model The Annals of Thoracic Surgery November 2021 Laura (..)
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content